While radiomics technology has been applied to early lung cancer diagnosis and prognostic stratification [14], there is limited research integrating radiomics and molecular biology to predict specific molecular markers like TACC3, which could guide personalized treatment. Here, TACC3 is linked to lung carcinoma.